Last updated: 11/03/2018 12:36:35
Study to identify and characterize bacteria causing Acute Otitis Media in South African children
GSK study ID
112135
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Identification and characterization of the bacteria causing Acute Otitis Media (AOM) episodes in HIV-positive and HIV-negative children in South Africa
Trial description: The purpose of this study is to identify and characterize the bacteria causing acute otitis media episode in HIV-positive and HIV-negative children (>=3 months to <5 years) in South Africa. Middle ear fluid sampling either by tympanocentesis or by careful sampling of spontaneous otorrhoea will be done; nasopharyngeal aspirate and urine sample will also be collected from the subjects.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Occurrence of bacterial pathogens isolated from middle ear fluid samples in HIV-positive and HIV-negative subjects.
Timeframe: Not Applicable.
Secondary outcomes:
Occurrence of bacterial serotypes.
Timeframe: Not Applicable.
Antimicrobial susceptibility of different bacteria isolated from middle ear fluid samples as assessed by standard microbiological techniques.
Timeframe: Not Applicable.
Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media.
Timeframe: Not Applicable.
Occurrence of spontaneous otorrhoea.
Timeframe: Not Applicable.
Occurrence of bacteria in acute otitis media cases with treatment failure and in new acute otitis media cases without treatment therapy.
Timeframe: Not Applicable.
Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine.
Timeframe: Not Applicable.
Frequency of concurrent respiratory viral infection coinciding with the episode of acute otitis media.
Timeframe: Not Applicable.
The comparison of above endpoints in HIV-positive and HIV-negative subjects.
Timeframe: Not Applicable.
Interventions:
Enrollment:
265
Primary completion date:
2010-03-05
Observational study model:
Cohort
Time perspective:
Prospective
Clinical publications:
Not applicable
- Inclusion criteria for all subjects:
- Age: >= 3 months and < 5 years at the time of enrolment.
- Hospitalised during the diagnosis of acute otitis media or during treatment.
- Otitis externa or otitis media with effusion.
Inclusion and exclusion criteria
Inclusion criteria:
- Age: >= 3 months and < 5 years at the time of enrolment.
- Signs, symptoms, and conditions:
- One of the functional or general signs of otalgia,, conjunctivitis, fever and either
- Paradise’s criteria or
- Spontaneous otorrhoea of less than 24 hours.
- Subject will be included as a treatment failure case.
- Written informed consent obtained from parent or guardian prior to study start. Inclusion criteria for HIV-positive subjects:
- Documented HIV-positive status as given in subject’s medical records. or
- Subjects referred from paediatric HIV clinic. Inclusion criteria for HIV-negative subjects (including presumed negative children)
- Children who have been tested HIV-negative.
- Children whose mothers volunteer to have tested HIV-negative whilst pregnant with the index case and the child is free to any World Health Organization Grade II stigmata of HIV/acquired immunodeficiency syndrome.
- Children who do not fulfil the World Health Organization staging for HIV infection / immunosuppression.
Inclusion criteria for all subjects:
Exclusion criteria:
- Otitis externa or otitis media with effusion.
- Presence of a transtympanic aerator.
- Systemic antibiotic treatment received for a disease other than acute otitis media in the 72 hours prior to enrolment.
- Receiving antimicrobial prophylaxis for recurrent acute otitis media but excluding cotrimoxazole or isoniazid prophylaxis in HIV exposed children.
- Provision of antibiotic by paediatrician/ENT specialist at the enrolment visit prior to the sampling of the middle ear fluid or spontaneous Otorrhoea.
- Children on antibiotics for acute otitis media who are clinically improving.
Hospitalised during the diagnosis of acute otitis media or during treatment.
Trial location(s)
Study documents
No study documents available.
Results overview
No study documents available
Recruitment status
Study complete
Actual primary completion date
2010-03-05
Actual study completion date
2010-03-05
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website